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LDL receptor-related proteins 5 and 6 (LRP5/6) are
coreceptors for Wnt growth factors, and also bind
Dkk proteins, secreted inhibitors of Wnt signaling.
The LRP5/6 ectodomain contains four b-propeller/
EGF-like domain repeats. The first two repeats,
LRP6(1-2), bind to several Wnt variants, whereas
LRP6(3-4) binds other Wnts. We present the crystal
structure of the Dkk1 C-terminal domain bound to
LRP6(3-4), and show that the Dkk1 N-terminal
domain binds to LRP6(1-2), demonstrating that
a single Dkk1 molecule can bind to both portions of
the LRP6 ectodomain and thereby inhibit different
Wnts. Small-angle X-ray scattering analysis of
LRP6(1-4) bound to a noninhibitory antibody frag-
ment or to full-length Dkk1 shows that in both cases
the ectodomain adopts a curved conformation that
places the first three repeats at a similar height rela-
tive to the membrane. Thus, Wnts bound to either
portion of the LRP6 ectodomain likely bear a similar
spatial relationship to Frizzled coreceptors.
INTRODUCTION
Wnt growth factors have essential roles in specifying cell fate
during embryogenesis and the renewal of tissues in the adult
(Clevers, 2006; Logan and Nusse, 2004; Reya and Clevers,
2005). In the Wnt/b-catenin pathway, Wnts bind to two corecep-
tors: 7-transmembrane helix Frizzled (Fzd) proteins, and a single-
pass transmembrane receptor, LDL receptor-related protein 5 or
6 (LRP5/6) (Clevers, 2006; Logan and Nusse, 2004; MacDonald
et al., 2009). Wnt binding to Fzd and LRP5/6 leads to phosphor-
ylation of the LRP5/6 cytoplasmic tail, which inhibits b-catenin
destruction; the stabilized b-catenin acts as a transcriptional
coactivator of Wnt target genes. Inappropriate activation of
this pathway is associated with a number of cancers and other
diseases (Clevers, 2006; Logan and Nusse, 2004; MacDonald
et al., 2009).
The importance of LRP5/6 in Wnt signaling is highlighted by
natural and experimentally derived mutations. Mutants of the
Drosophila Lrp5/6 ortholog Arrow are phenotypically similar to
wingless (dWnt-1) mutants (Wehrli et al., 2000). In mice, deletion
of both LRP5 and LRP6 causes embryonic lethality due to failure
of gastrulation (Kelly et al., 2004). Deletion of LRP6 results in peri-862 Developmental Cell 21, 862–873, November 15, 2011 ª2011 Elsnatal lethality with midbrain and hindbrain defects, posterior
truncation, and abnormal limb development, whereas deletion
of LRP5 leads to osteoporosis and other metabolic defects
(Kato et al., 2002; Pinson et al., 2000). Missense mutations in
LRP5 associated with autosomal recessive osteoporosis-pseu-
doglioma syndrome (OPPG) compromise Wnt signaling (Gong
et al., 2001). Missense mutations in the LRP5 ectodomain are
also associated with autosomal dominant and recessive familial
exudative vitreoretinopathy (FEVR), although the biochemical
consequences of these changes have not been reported (Jiao
et al., 2004; Qin et al., 2005; Toomes et al., 2004).
The LRP5/6 ectodomain comprises four repeating units of
a six-bladed b-propeller connected to an EGF-like domain,
followed by three LDLR-type A repeats (Figure 1A). A study using
purified proteins demonstrated that Wnt9b binds to an LRP6
construct comprising the first two propeller/EGF repeats, desig-
nated here LRP6(1-2), whereas Wnt3a binds to LRP6(3-4)
(Bourhis et al., 2010). Deletion mutagenesis and antibody block-
ing experiments have implicated LRP6(1-2) in binding to Wnts 1,
2, 2b, 6, 8a, 9a, 9b, and 10b, whereas LRP6(3-4) is required
for Wnt3a binding (Ai et al., 2005; Gong et al., 2010; Itasaki
et al., 2003; Mao et al., 2001a; Zhang et al., 2004). Antibodies
to different regions of LRP6 can inhibit Wnt signaling, presum-
ably by competing with Wnts directly or inhibiting formation of
ternary receptor complexes, whereas others enhance signaling,
possibly by receptor clustering (Binnerts et al., 2009; Gong et al.,
2010; Yasui et al., 2010).
Dickkopf (Dkk) proteins are secreted modulators of Wnt
signaling that bind to LRP5/6 with high affinity (Bourhis et al.,
2010; Niehrs, 2006). Deletion of Dkk1 results in embryonic
lethality including loss of anterior head structures and fused
vertebrae (Mukhopadhyay et al., 2001), and Dkk2 null mice
show osteopenia and blindness (Li et al., 2005a; Mukhopadhyay
et al., 2006). High bone mass (HBM) disease arises from
missense mutations in LRP5 repeat 1 that reduce or ablate the
ability of inhibitors, including Dkks, to downregulate Wnt
signaling (Ai et al., 2005; Balemans et al., 2007). Dkks also bind
to the cell-surface receptor Kremen, which appears to control
internalization of LRP5/6 under some circumstances (Mao and
Niehrs, 2003; Mao et al., 2002; Seme¨nov et al., 2008; Wang
et al., 2008).
Each of the four vertebrate Dkk family members consists of
two conserved cysteine-rich domains, designated here Dkk_N
and Dkk_C, connected by a linker of 50 residues in Dkks 1,
2, and 4 (Figure 1A). Dkk1_C and Dkk2_C alone antagonize
Wnt signaling (Brott and Sokol, 2002; Li et al., 2002; Mao and
Niehrs, 2003), consistent with the absence of Dkk_N in Dkks ofevier Inc.
Figure 1. Dkk1_C Mediates Binding to LRP6(3-4)
(A) Primary structures of human LRP6 and Dkk1. The conserved cysteine-rich N- and C-terminal domains of Dkk1 are denoted ‘‘N’’ and ‘‘C.’’ SS, signal sequence;
LA, LDLR type A repeat, TM, transmembrane segment. Boundaries of constructs used in this study are indicated below each protein.
(B) ITC binding of LRP6(3-4) to either full-length Dkk1 (left) or Dkk1_C (right). See also Table S1.
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LRP6-Dkk1 Interactionslower organisms such as Hydra (Guder et al., 2006). Dkk1 binds
to both LRP6(1-2) and LRP6(3-4) (Bafico et al., 2001; Binnerts
et al., 2009; Bourhis et al., 2010; Li et al., 2005b; Liu et al.,
2009; Mao et al., 2001a; Zhang et al., 2004), but the regions of
Dkk1 required for these interactions are unknown.
Here, we describe the crystal structure of human LRP6(3-4)
bound to human Dkk1_C, and a low-resolution picture of the
full LRP6(1-4) region derived from small-angle X-ray scattering
(SAXS). We show that Dkk1 acts as a bipartite inhibitor of Wnt
binding, with Dkk1_N binding to LRP6(1-2) while Dkk1_C binds
to LRP6(3-4). The LRP6(1-4) region adopts a twisted, curved
conformation that likely places its multiple Wnt binding surfaces
at comparable heights from the membrane. The low resolution
envelopes of LRP6(1-4) bound to a Fab fragment of amonoclonal
antibody or to Dkk1 indicate that the receptor adopts similar
conformations in both cases.DevelopmeRESULTS
The Dkk1 C-Terminal Domain Specifies Binding
to LRP6(3-4)
The three LDLR-A motifs at the C terminus of the LRP6 ectodo-
main do not affect Wnt signaling nor its inhibition by Dkk1
(Mao et al., 2001a), so our studies employed only the
b-propeller/EGF repeats. The second two repeats, LRP6(3-4)
(Figure 1A), are required for Dkk1 inhibition of Wnt signaling.
Isothermal titration calorimetry (ITC) (Figure 1B) revealed that
Dkk1 forms a 1:1 complex with LRP6(3-4), consistent with quan-
titative N-terminal sequencing (Table S1A, available online), and
binds with a Kd of 67 nM (Figure 1B), in good agreement with bio-
layer interferometry measurements (Bourhis et al., 2010). Only
the conserved C-terminal cysteine-rich region of Dkk1, starting
at residue 178 and designated Dkk1_C, was protected whenntal Cell 21, 862–873, November 15, 2011 ª2011 Elsevier Inc. 863
Table 1. Crystallographic Data
Native HgCl2
Data Collectiona
Space group P212121 P212121
Unit cell lengths a,b,c (A˚) 96.0, 108.0,
173.1
96.2, 107.6,
172.4
Wavelength (A˚) 1.0039 1.0039
Resolution (A˚) 45.8–2.80
(2.90–2.80)
45.8–3.08
(3.19–3.08)
Unique reflections 45,089 32,773
Multiplicity 3.4 (3.4) 3.6 (3.6)
Completeness (%) 99.7 (99.9) 97.0 (94.7)
<I/ s (I) > 23.8 (2.6) 12.2 (1.6)
Rmerge
b (%) 6.1 (51.9) 10.4 (70.6)
Model Refinement
Resolution, A˚ 45.8–2.80
No. reflections work/test set 42,788/2235
Number of residues
Protein 1298
Carbohydrate 16
Water 56
Rcryst
c (%) 19.4
Rfree
c (%) 25.1
Rmsd bonds (A˚) 0.003
Rmsd angles () 0.69
Ramachandran plotd
Percentage in favored regions 93.2
Percentage in additional
allowed regions
6.7
Percentage outliers 0.1
Average temperature factor (A˚2)
Lrp6(3-4) chain A 66.1
Lrp6(3-4) chain B 56.8
Dkk1_C 61.0
Solvent 42.8
aData weremeasured at 100 K at beamline 11-1 at the Stanford Synchro-
tron Radiation Laboratory (SSRL) and were integrated and scaled with
HKL2000 (Otwinowski and Minor, 1997). Values in parentheses are for
the highest resolution shell. Rmsd, root mean square deviation.
b Rmerge = ShSIj(II(h) < I(h) > j / ShSI(h), where II(h) is the Ith measurement
of reflection h, and < I(h) > is the weighted mean of all measurements of h.
c R = ShjFobs(h)j  jFcalc(h)j j / ShjFobs(h)j. Rcryst and Rfree were calculated
using the working and test reflection sets, respectively.
d As defined in Molprobity (Chen et al., 2010).
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LRP6-Dkk1 Interactionsthe LRP6(3-4)-Dkk1 complex was digested with trypsin (data not
shown). ITC revealed that Dkk1_C binds to LRP6(3-4) with the
same thermodynamics as full-length Dkk1 (Figure 1B), demon-
strating that that Dkk1_C harbors the full set of residues that
bind to LRP6(3-4).
The crystal structure of the LRP6(3-4)-Dkk1_C complex was
determined at 2.8 A˚ resolution (Table 1). Surprisingly, the asym-
metric unit of the crystal contains two copies of LRP6(3-4)
and a single copy of Dkk1_C. The crystallized material was864 Developmental Cell 21, 862–873, November 15, 2011 ª2011 Elspurified by mixing LRP6(3-4) with an excess of Dkk1_C at
concentrations >100 3 Kd to ensure that all of the LRP6(3-4)
would be bound to Dkk1_C. The mixture was applied to a size
exclusion chromatography column, and the two proteins coe-
luted in a volume corresponding to 80 kDa, the expected size
of a 1:1 complex. However, quantitative N-terminal Edman
sequencing of the fractions containing the two proteins revealed
a molar ratio of 2 LRP6(3-4):1 Dkk1_C (Table S1B). These results
suggested that the purified (and crystallized) material is an equi-
molar mixture of a 1:1 LRP6(3-4)-Dkk1_C complex and unbound
LRP6(3-4) that was unresolved on the size exclusion column; a 2
LRP6(3-4):1 Dkk1_C complex would be expected to migrate at
150 kDa. Native PAGE confirmed that the material used for
crystallization was an equimolar mixture of complex and
unbound LRP6(3-4) (data not shown). As the complex was
prepared under conditions that should have ensured 100%
complex formation, the presence of bound and unbound
LRP6(3-4) cannot be readily explained.
All residues of LRP6(3-4) are visible in both copies in the
crystal, except for the loop comprising residues 1006–1012. In
both copies, at least one sugar is visible at each of the five pre-
dicted N-linked glycosylation sites (Figure S1). The model of
Dkk1_C comprises residues 182–264, except that the loop span-
ning residues 250–258 is disordered.
Structure of LRP6(3-4) and Dkk1_C
Each repeat of LRP6(3-4) consists of a six-bladed b-propeller
attached by a 7–8 residue linker to an EGF-like domain that
packs tightly against the propeller (Figure 2A). Each blade
consists of four antiparallel b strands, with the first strand, A,
occupying the position closest to the pseudo 6-fold symmetry
axis of the propeller (Figure 2A). The B strands of blades 2–6
harbor the Tyr-Trp-Thr-Asp (YWTD) repeat motif that character-
izes these structures (Figure S1). As in other YWTD b-propeller
structures, the amino acid sequence of the barrel begins with
strand B of blade 1, and the last b strand in the sequence is
the A strand of blade 1, thereby closing the barrel (Jeon et al.,
2001) (Figure S1).
The structures of the two LRP6 b-propeller/EGF repeats are
very similar to one another and to the single repeats found in
the LDL receptor and the basement membrane protein nidogen
(Jeon et al., 2001; Takagi et al., 2003). The two copies of repeat 3
or those of repeat 4 superimpose closely (rootmean square devi-
ation [rmsd] = 1.2 A˚). The rmsd of repeats 3 and 4 to the LDLR
repeat are 1.7 A˚ (283 residues, 34.3% identity) and 2.1 A˚ (278
residues, 25.9% identity), respectively. The largest variation
among these b-propeller/EGF repeat structures occurs in the
connection between the propeller and the EGF-like domain.
Nonetheless, the EGF-like domain retains a very similar disposi-
tion with respect to the b-propeller in all cases.
TheLRP6(3-4) structure provides a viewof tandemb-propeller/
EGF repeat modules. Just four resides connect the end of the
repeat 3 EGF-like domain and the first b strand of the repeat
4 propeller, and the two repeats interact extensively with one
another. The inter-repeat interface buries 1819 A˚2 of surface
area with amixture of polar and nonpolar interactions (Figure 2B;
Table S2). The two crystallographically independent copies show
limited flexibility: if only repeats 3 are superimposed, then repeats
4 differ by a rotation of about 7.evier Inc.
Figure 2. Structures of LRP6(3-4) and Dkk1_C
(A) The LRP6(3-4) structure, viewed down the pseudo-6-fold symmetry axis of propeller 3 (top) or toward the side (bottom). Blades are numbered in repeat 3, and
individual strands are labeled in blade 1.
(B)Closeupof the repeat3–4 interface.Repeats3and4, respectively, are shown indarkerand lighter shades. Interactingsidechainsare shown instick representation.
Polar interactions are shown with dashed lines. Repeat 4 residue labels are underlined. The complete list of interactions is given in Table S2. See also Figure S1.
(C) Ribbon representation of Dkk1_C. Disulfide bridges are show in green. The loop between b strands 5 and 6 is disordered. See also Figure S2.
(D) Superposition of human Dkk1_C structure (gold) with the NMR solution structure of mouse Dkk2_C (blue) (PDB entry 2JTK).
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LRP6-Dkk1 InteractionsThe Dkk1_C structure can be described as two subdomains,
each consisting of three antiparallel b strands, that are con-
nected by a long loop that contains a short a helix (Figure 2C).
The fold is stabilized by five disulfide bridges. The molecule is
rather flat, with approximate dimensions 30 3 30 3 15 A˚. The
overall structure is similar to that of the mouse Dkk2_C deter-
mined by NMR (Chen et al., 2008) (rmsd = 2.4 A˚ for 63 residues;
61.9% identity) (Figure 2D), but there are two significant differ-
ences. First, a portion of the long connection between strands
4 and 5 is relatively flexible in the unbound, solution NMR struc-
ture, but in the crystal structure this region interacts with LRP6.
This region is almost identical in sequence between the two
proteins, implying that the difference in structure is due to
binding to LRP6. Conversely, the loop between b strands 5
and 6 in the NMR structure would clash with the LRP6 propeller,
whereas this region is disordered in the present structure.
The LRP6(3-4)-Dkk1 Interaction
A single Dkk1_C molecule is sandwiched between the two inde-
pendent copies of LRP6(3-4) in the asymmetric unit of the crystal
(Figure 3A). In both copies of LRP6, the same face of the repeat 3
propeller interacts with Dkk1_C, and in both cases the Dkk1_C
molecule is not centered on the propeller but offset toward
blades 3, 4, and 5. This face of the propeller presents a concave,
amphitheater-like structure that serves as the binding surface for
ligands, as seen in the nidogen-laminin complex (Takagi et al.,
2003), and the intramolecular interaction with LDLR-A repeats
in the low pH LDL receptor (Rudenko et al., 2002). In the LRP6
repeat 3 propeller, this surface is electrostatically negative (Fig-
ure 3B), consistent with the positively charged nature of bothDevelopmeDkk1_C (calculated pI = 9.2) and most Wnts (average pI = 8.9
for the 19 human Wnts). In contrast, the equivalent face of the
repeat 4 barrel is more positively charged (Figure 3B), and is
exposed in this structure.
The interface between Dkk1_C and copy B of LRP6(3-4)
buries 2033 A˚2 of surface area. The core of the interface features
a cluster of aromatic and nonpolar side-chain interactions near
the center of the LRP6 repeat 3 b-propeller (Figures 3C and
3D; Table S3). In addition, Dkk1 His204 forms a hydrogen
bond with LRP6 Glu708, Glu232 forms a salt bridge with
Arg792, and several side chains also form hydrogen bonds
with backbone amide nitrogen and carbonyl oxygen atoms. A
second cluster of interactions occurs toward the rim of the
LRP6 amphitheater, at blades 4 and 5: Dkk1 Val219 and
Leu260 pack against Pro771 and Thr812, Arg236 forms a salt
bridge with Asp811, and Arg224 forms a hydrogen bond with
Asn813 and the backbone at 812. Finally, there is a single salt
bridge made by Dkk1 Glu185 and LRP6 Arg1184, the only
contact between Dkk1 and LRP6 repeat 4.
In contrast to the extensive nonpolar packing interactions
between Dkk1 and LRP6 chain B, the interface with copy A
involves mostly polar Dkk1 residues and is somewhat smaller
(1830 A˚2). These Dkk1 residues interact with many of the same
LRP6 side chains that form the interfacewith the aromatic cluster
on the other face of Dkk1_C (Figure S3; Table S4). Most notable
is the interaction of Lys226 methylene groups with the same
aromatic and aliphatic residues that mediate contacts between
copy B and the Dkk1 aromatic cluster; the terminal amine is
neutralized by an electrostatically negative region in the center
of the amphitheater. Only one nonpolar side chain of Dkk1,ntal Cell 21, 862–873, November 15, 2011 ª2011 Elsevier Inc. 865
Figure 3. Dkk1_C Interacts with Both Copies of LRP6(3-4) in the Asymmetric Unit
(A) Overall structure of the asymmetric unit. LRP6(3-4) copy A is shown in green and copy B in cyan, with repeats 3 and 4 respectively shown in darker and lighter
shades. The single copy of Dkk1_C is shown in gold.
(B) Electrostatic surface of LRP6(3-4) copy B bound to Dkk1_C. Red represents regions of negative charge, blue positive, contoured from 5 to +5 kBT/e.
(C and D) Closeup view of the LRP6(3-4) copy B interface with Dkk1_C, looking down the pseudo-6-fold axis of LRP6 propeller 3 (C) or viewed from the side (D).
Interacting residues are shown in stick representation. Polar interactions are shown with dashed lines. Dkk1 residue labels are italicized. The complete list of
interactions is given in Table S3. Glu708 and Asp811 are highlighted in red ovals. See also Figures S1, S2, and S5. The copy A interface is shown in Figure S3 and
contacts listed in Table S4.
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LRP6-Dkk1 InteractionsLeu231, contacts LRP6 in this interface, packing against the
aromatic ring of Tyr875. In addition to these interactions, LRP6
side chains Arg751, Arg792, and Trp850 form hydrogen bonds
with the main chain of Dkk1.
To determine the biologically relevant interface, we mutated
several Dkk1 residues that contact LRP6(3-4) in the crystal and
tested their ability to inhibit Wnt3a signaling (Figure 4A). Muta-
tions in the interface with copy B, including E232K, W206A,
F234K, abolished or significantly reduced inhibition, consistent866 Developmental Cell 21, 862–873, November 15, 2011 ª2011 Elswith the behavior of charge reversal mutations H204E, K211E,
R236E, and H261E in this interface described previously for
mouse Dkk1 (human Dkk1 numbering shown) (Chen et al.,
2008). In contrast, mutation of residues in the interface with
copy A had only small (K226E) or no (H229E) effects on the ability
of Dkk1 to inhibit signaling, as did two other published mutations
of mouse Dkk1 in this interface, K226A and R191E (human
numbering) (Wang et al., 2008). This polar face of Dkk1_C has
been shown to interact with Kremen proteins (Wang et al.,evier Inc.
Figure 4. Effect of Dkk1 and LRP6 mutations on Wnt3a activity
LSL cells were treated with Wnt3a conditioned media plus Dkk1_C, wild-type
Dkk1 or a mutant. The activity from treatment with Wnt3a CM is taken to be
100%. Error bars denote standard deviation.
(A) Dkk1 mutants.
(B) LRP6(3-4) mutants.
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LRP6-Dkk1 Interactions2008), which may explain the small effect of K226E on Wnt
reporter activity, as mutation of this residue to either Ala or Glu
was shown to have no effect on LRP6 binding (Wang et al., 2008).
The mutational data and the 1:1 stoichiometry observed for
the LRP6(3-4)-Dkk1_C interaction indicate that the interface
between Dkk1 and LRP6 chain B in the crystal represents the
high-affinity and likely biologically relevant interaction between
these two proteins. The behavior of the K226E mutant may
suggest a role for the polar interface with chain A at the cell
surface, although SAXS measurements at high concentrations
do not support a 2 LRP6: 1 Dkk1 stoichiometry (see below).
Conservation of the LRP5/6 Interface with Dkk
Dkk1_C residues that directly contact LRP6 are conserved in
Dkk2 and Dkk4, as expected from the ability of these Dkk iso-
forms to inhibit Wnt signaling, as well as the Hydra homolog (Fig-
ure S2). In contrast, most of these positions differ in Dkk3,
consistent with earlier studies indicating that Dkk3 is a divergent
family member that does not inhibit Wnt signaling (Niehrs, 2006).
The amino acid sequences of human LRP5 and LRP6 are 71%
identical, and almost all LRP6 residues that interact with Dkk1_C
are identical in LRP5 (Figure S1). The four propeller/EGF repeats
of human LRP5/6 are very similar to one another, with few rela-
tive insertions and deletions: within LRP6, repeat 3 shares
47% sequence identity with repeats 1 and 2, and while its iden-
tity to repeat 4 is only 33%, the structures of repeats 3 and 4 are
very similar. Consistent with its lower sequence homology, the
concave barrel surface of repeat 4 is poorly conserved, both in
electrostatic character (Figure 3B) and in the residues that form
the interface with Dkk1. For example, the hydrophobic clusterDevelopmein the amphitheater of propeller 3 (Figure 3C) is present in
repeats 1 and 2, but not 4.
A key difference among repeats occurs at the position equiv-
alent to Asp811 in repeat 3, which forms a salt bridge with
Arg236 of Dkk1: a lysine is present at this position in repeats 1
and 2. Since R236E in Dkk1 ablates binding (Chen et al.,
2008), the equivalent charge reversal caused by the presence
of lysine on the LRP6 surface would be expected to prevent
Dkk1_C binding. Interestingly, an arginine is present in this
position in repeat 3 of the Drosophila LRP5/6 homolog Arrow,
which correlates with the absence of Dkk proteins in this
organism. Also, several substitutions in repeats 1 and 2 of
LRP5 or 6 would appear to diminish binding to Dkk1_C. Ile681,
which forms a nonpolar contact with Dkk1 Phe205, is Val in
repeat 1 but Asp in repeat 2. Tyr706 is replaced by Ser, His, or
Asp in repeats 1 and 2, and Arg792 is replaced by Trp in repeats
1 and 2.
Wnt3a and Dkk1 Bind to an Overlapping Surface of LRP6
The simplest model for inhibition of Wnt binding by Dkks is direct
competition for a common binding site on LRP5/6. We intro-
duced charge reversal mutations E708K and D811K into
LRP6(3-4) that, based on the effects of Dkk1 H204E and
R236E mutations (Chen et al., 2008), would disrupt the polar
interactions with Dkk1, and compared the ability of purified
wild-type, E708K and D811K LRP6(3-4) to inhibit signaling by
competing with cell surface LRP6 for Wnt3a. Glu708 lies at the
heart of the LRP6 repeat 3 amphitheater, and Asp811 is near
the rim of blade 5 (Figures 3C and 3D). Inhibition by wild-type
LRP6(3-4) required a concentration of 5 mM, similar to previous
reports using this assay (Bourhis et al., 2010; Liu et al., 2009).
The D811K mutant behaved similarly to wild-type, but E708K
showed only weak inhibition at the highest concentration tested
(Figure 4B). These data suggest that the footprint of Wnt3a
partially overlaps that of Dkk1_C such that they directly compete
for LRP6. Dkk1_C is a weaker inhibitor of Wnt3a signaling than
full-length Dkk1 (Figure 4A), which may be due to its weaker
affinity for LRP6. However, Wnt3a binds to LRP6(1-4) 20 times
more strongly than to LRP6(3-4) (Bourhis et al., 2010), suggest-
ing that there are additional interactions of Wnt3a involving the
LRP6(1-2) region that are affected only by full-length Dkk1 and
not Dkk1_C, or that LRP6(1-2) influences the conformation of
LRP6(3-4).
Dkk1 Is a Bipartite Inhibitor of LRP-Wnt Interactions
Purified Wnt9b and Wnt3a bind to independent sites on LRP6:
Wnt9b binds to LRP6(1-2), whereas Wnt3a binds to LRP6(3-4),
and both can bind simultaneously to LRP6(1-4) (Bourhis et al.,
2010). Full-length Dkk1 inhibits both Wnts from binding to their
cognate LRP6 fragment (Bourhis et al., 2010). Dkk1 binds to
LRP6(1-4) with a Kd of 3 nM, whereas binding to LRP6(1-2) or
LRP6(3-4) is 21 or 7 times weaker, respectively (Bourhis et al.,
2010). One interpretation of these data is that the same portion
of Dkk1 binds to homologous surfaces on either half of the
LRP6 ectodomain, such that two copies of Dkk1 bind to one
LRP6(1-4). However, the two proteins appear to form a 1:1
complex (see below, and Bafico et al., 2001; Mao et al.,
2001a), and sequence and mutational data (see above) indicate
that Dkk1_C is unlikely to bind to repeats 1 or 2. Thesental Cell 21, 862–873, November 15, 2011 ª2011 Elsevier Inc. 867
Figure 5. Dkk1_N and Dkk1_C Bind to Distinct Regions of the LRP6 Ectodomain
(A) LRP6(1-2) at 2.5 mMwasmixed with 12.5 mMDkk1_N (left) or 12.5 mMDkk1_C (right) and run on a Superdex 200 column. An anti-His6 western blot was used to
visualize the proteins in the indicated fractions. Dkk1_C transfers poorly for western blotting, as seen by the difference in band intensities versus Dkk1_N even
though the same amount of protein is present in both experiments. The overexposed western blot of lanes 3–6 shown in the Dkk1_C experiment demonstrates
that no Dkk1_C coeluted with LRP6(1-2).
(B) ITC measurement of Dkk1_N binding to LRP6(1-2). See also Figure S4 for alternative binding assay.
(C) LRP6(1-2) at 2.5 mM was mixed with 2.5 mM Dkk1_N and 12.5 mM Fab135 and run on a Superdex 200 column. Fractions were analyzed by SDS-PAGE. The
upper gel was stained with Coomassie blue to visualize LRP6(1-2) and Fab135; the lower gel was analyzed by western blot with anti-His6 to visualize LRP6(1-2)
and Dkk1.
(D) mAb135 and Dkk1 can both bind to LRP6(1-4). LRP6(1-4)-Dkk1 complex at 2 mM was incubated with the indicated concentration of mAb135, run on native
PAGE, and analyzed by Coomassie blue staining (left) and western blot with anti-Dkk1 (right). The antibody shifts the LRP6(1-4)-Dkk1 complex upward to the
middle band, which still contains Dkk1 as shown by the western blot.
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LRP6-Dkk1 Interactionsobservations suggest that the higher affinity of full-length Dkk1
binding is due to the N-terminal portion of Dkk1.
We prepared a Dkk1_N construct spanning residues 31–142
(Figure 1A). Dkk1_N, but not Dkk1_C, associated with LRP6(1-2)
on a size exclusion chromatography column (Figure 5A). ITC and
native gel shift assays (Figure 5B; Figure S4) showed that
Dkk1_N binds to LRP6(1-2) with an apparent Kd of 66 nM, with
a 1:1 stoichiometry (Figure 5B; Figure S4). Conversely, we
observe no binding of Dkk1_N to LRP6(3-4) by gel filtration or
native gel shift assays (data not shown). These data indicate
that full-length Dkk1 binds to LRP6 in a bipartite manner: the868 Developmental Cell 21, 862–873, November 15, 2011 ª2011 ElsN-terminal region interacts with the repeat 1–2 region, whereas
the C-terminal region binds to repeat 3.
LRP5 point mutations associated with HBM disease occur in
positions on the repeat 1 propeller equivalent to residues in
repeat 3 that either directly interact or position other amino acids
to interact with Dkk_C (Figures S1 and S5) (Ai et al., 2005;
Balemans et al., 2007; Chen et al., 2008; Takagi et al., 2003;
Zhang et al., 2004). The conservation of both sequence and
length of the repeat 1 propellers of LRP5 and LRP6 (Figure S1),
and the observation that the G158V mutation in LRP6, homolo-
gous to the LRP5 HBM mutation G171V, has equivalent effectsevier Inc.
Figure 6. SAXS Reconstructions of LRP6(1-4) Bound to Fab135 or Dkk1
(A) SAXS data for the LRP6(1-4)-Fab135 (red) and LRP6(1-4)-Dkk1 (blue) complexes, offset on the y axis for clarity. The solid line shows the scattering curve
calculated from the LRP6(1-4)-Fab135 model shown in (B), c2 = 3.1. See also Figure S6.
(B) Ab initio reconstruction (gray spheres) of the LRP6(1-4)-Fab135 complex, with a model of the LRP6(1-4)-Fab135 superimposed. LRP6 repeats 1, 2, 3, and 4
are shown in red, orange, teal, and blue, respectively, and the Fab is shown in yellow.
(C) Ab initio reconstruction of the LRP6(1-4)-Dkk1 complex. The model of the LRP6(1-4) region shown in (B) is superimposed on the envelope. The position of
Dkk1_C after superposition of the LRP6(3-4)-Dkk1_C crystal structure on the SAXS model is shown in gold.
(D) Alternative view of LRP6(1-4) SAXS-derivedmodel, oriented with repeats 1–3 roughly coplanar and the C terminus of repeat 4 near the bottom, illustrating that
the Wnt-binding regions of the receptor likely have similar heights with respect to the membrane and Fzd. Wnt, Fzd, and the three LDLR-A repeats, the
transmembrane anchor, and the cytoplasmic domain of LRP5/6 are shown schematically.
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2006), allowed us to test whether this surface is involved in
Dkk1_N binding. The anti-LRP6 monoclonal antibody mAb135
enhancesWnt3a signaling, and binds to an epitope that includes
LRP6 Ser243 (Binnerts et al., 2009). Ser243 is located on the rim
of repeat 1 amphitheater adjacent to a conserved Trp that in
repeat 3 mediates interactions with Dkk1_C (Figure S1). The
Fab fragment of this antibody (Fab135) displaced Dkk1_N from
LRP6(1-2) (Figure 5C), consistent with the binding of Dkk1_N
to the repeat 1 amphitheater. Moreover, as expected from the
high-affinity Dkk1_C-LRP6(3-4) interaction, mAb135 bound to,
but did not compete full-length Dkk1 from, LRP6(1-4) (Figure 5D).
Since Dkk1 binds to LRP6(3-4) more weakly than to LRP6(1-4),
the ability of mAb135 to inhibit internalization (Binnerts et al.,
2009) may be due to weakening the overall affinity of Dkk1 for
LRP6 such that formation of ternary complexes with Kremen is
less likely.
The observation that mAb135 does not displace Dkk1 from
LRP6(1-4) implies that the two proteins bind with a 1:1
stoichiometry: if two Dkk1 molecules bound simultaneously toDevelopmeLRP6(1-4), we would expect a loss of the total Dkk1 band
intensity with increasing antibody concentration in Figure 5D.
We examined the stoichiometry of the complex directly with
small-angle X-ray scattering (SAXS) (Figure 6A; Figure S6A).
The scattering intensity at zero scattering angle I(0) allows accu-
rate determination of molecular mass (Orthaber et al., 2000).
Including the N-linked carbohydrate, the calculated masses of
LRP6(1-4) and Dkk1 are approximately 152 and 27.5 kDa. I(0)
analysis of the LRP6(1-4)-Dkk1 data reveals a molecular mass
of 185 ± 5 kDa (Figure S6A). Thus, the SAXS data reveal a 1:1
stoichiometry for the LRP6(1-4)-Dkk1 complex at the highest
concentrations experimentally accessible.
Structure of the LRP6(1-4) Region
We used SAXS to determine the overall conformation of the
LRP6 repeat 1–4 region. The uncomplexed protein was not
sufficiently well behaved for SAXS measurements, nor was its
complex with Dkk1_C. However, both LRP6(1-4)-Fab135 and
LRP6(1-4)-full-length Dkk1 complexes gave excellent SAXS
data (Figure 6A; Figure S6). Ab initio reconstructions ofntal Cell 21, 862–873, November 15, 2011 ª2011 Elsevier Inc. 869
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a bent and twisted conformation for LRP6(1-4).
The LRP6(1-4)-Fab complex structure was modeled using
the LRP6 repeat structures determined here and a Fab from
the Protein Data Bank. No attempt was made to model the
12 kDa of N-linked carbohydrate on LRP6(1-4). One end of
the envelope could easily accommodate the crystal structure
of LRP6(3-4), and the other end was readily fit with the Fab
model. A homology model of LRP6(1-2) was made from the
crystal structure of LRP6(3-4) with MODELER (Sali and Blundell,
1993). LRP6 repeat 1 was positioned such that Ser243 was
located near the antigen-combining site of the Fab. Significant
changes in the relative positions of repeats 1 and 2, and 2 and
3, were needed to fit the envelope. Some residues that mediate
contacts between repeats 3 and 4 are not conserved in the 1–2
and 2–3 interfaces: for example, Phe702, Trp744, andHis919 are
replaced by much smaller residues, including Gly in the case of
His919 (Figure 2B; Figure S1 and Table S2). Morever, a proline
present in the repeat 2–3 and 3–4 connections is replaced by
glycine in the 1–2 linker. These differences could allow for
different relative positions of the repeats than that observed for
3 and 4, and may also indicate that there is some flexibility
between these repeats. Because SAXS models are underdeter-
mined, several LRP6(1-4) models were consistent with the data,
but all had the same curved, twisted shape (Figure 6B).
The structure of the first 181 residues of Dkk1 is not known,
so we could not model the LRP6(1-4)-Dkk1 SAXS data in
detail. Nonetheless, the LRP6(1-4) model made for the Fab135
complex fits into the ab initio envelope of the Dkk1 complex (Fig-
ure 6C). Superposition of the Dkk1_C-repeat 3 complex coordi-
nates onto repeat 3 of the SAXSmodel shows Dkk1_C is accom-
modated in the envelope. Another significant unmodeled volume
lies near the amphitheater surface of the repeat 1 propeller. In
the SAXS-derived models, the repeat 1 amphitheater is roughly
80 A˚ away from the N-terminus of Dkk1_C. The linker between
the two cysteine-rich N and C-terminal domains of Dkk1, 2 and
4 is approximately 50 residues long (Figure S2), which could
easily span this distance. Also, the Kremen-binding surface of
Dkk1_C (Wang et al., 2008) faces outward and would be able
to interact with Kremen on the cell surface.
DISCUSSION
Our results, combined with the studies of Bourhis et al. (2010),
indicate that the two conserved regions of Dkk1 can inhibit all
Wnts from binding to LRP5/6. LRP5/6 repeat 3, which binds to
Dkk1_C, is needed for Dkk1 binding and Wnt1 antagonism
(Mao et al., 2001a; Zhang et al., 2004), yet Wnt1 and many other
Wnt variants appear to bind the LRP5/6(1-2) region (Gong et al.,
2010). Moreover, Dkk1_N by itself does not appear to inhibit
signaling (Brott and Sokol, 2002; Mao and Niehrs, 2003). Since
Dkk1_N binds to the LRP6(1-2) region, the interaction of
Dkk1_C with repeat 3 likely provides a high-affinity anchor that
makes Dkk1_N an effective inhibitor of Wnt binding at physiolog-
ical concentrations, consistent with the 21 times stronger
binding of Dkk1 to LRP6(1-4) compared with LRP6(1-2) (Bourhis
et al., 2010). Signaling by Wnts 1 and 8, which appear to bind
LRP6(1-2) (Gong et al., 2010), can be inhibited by Dkk1_C
although not as strongly as by full-length Dkk1 (Brott and Sokol,870 Developmental Cell 21, 862–873, November 15, 2011 ª2011 Els2002; Mao and Niehrs, 2003). We suggest that interaction with
Kremen receptors and receptor internalization, or inhibition of
receptor dimerization, mediate these effects (Binnerts et al.,
2009; Gong et al., 2010).
The Dkk_N region is not as strongly conserved as Dkk_C (e.g.,
40% identity between human Dkk1_N and Dkk2_N, versus 67%
for Dkk1_C and Dkk2_C), and studies with deletion and chimeric
constructs suggest that the differences between Dkk1 and 2
reside in Dkk_N (Brott and Sokol, 2002). The distinct biological
effects of Dkk1, 2, and 4 (Brott and Sokol, 2002; Krupnik et al.,
1999) may thus arise from differences in their interactions with
the LRP5/6(1-2) region.
Dkks likely inhibit Wnt signaling by directly competing with
Wnts for binding sites on LRP5/6. However, HBM mutations in
LRP5 diminish Dkk1, but not Wnt, binding to LRP5 (Ai et al.,
2005; Balemans et al., 2007), indicating that the Wnt binding
site on LRP5/6(1-2) is distinct from this portion of the repeat 1
surface (Figure S5) required for Dkk1_N binding. The other
portion of the repeat 1 amphitheater might contribute to the
Wnt interface, as well as the repeat 2 propeller. LRP5 missense
mutations R494Q, R570W and V667M that cause OPPG and
show diminished Wnt signaling (Gong et al., 2001) lie dispersed
on the side of the repeat 2 b-propeller barrel. A naturally occur-
ring mutation, R611C in LRP6 repeat 2 impairs Wnt3a-mediated
signaling (Mani et al., 2007). This position is equivalent to Val913
and Arg1227 of repeats 3 and 4, which mediate interactions
between the b-propeller and EGF-like domains within a repeat
and likely stabilize their relative positions. We speculate that
these mutations may directly prevent Wnt interactions with
repeat 2, or they might alter the receptor conformation so as to
make the Wnt binding site inaccessible or prevent receptor
clustering.
Deletion of the entire extracellular region of LRP6 results in
a constitutively active receptor, indicating that unliganded
LRP5/6 is autoinhibited (Liu et al., 2003; Mao et al., 2001a,
2001b). Thus, Dkks may stabilize an autoinhibited conformation,
whereas aWntmight stabilize a distinct structure. The conforma-
tion of LRP6 bound to mAb135 should be ‘‘active’’ since the
antibody enhances Wnt3a signaling (Binnerts et al., 2009). The
LRP6(1-4) model derived from the Fab135 SAXS data appears
compatible with the LRP6(1-4)-Dkk1 envelope, so potential
conformational differences would appear to be small. Note,
however, that the uncertainties of these low-resolution (40 A˚)
reconstructions do not allow us to conclude that the receptor
conformation the same in both cases.
Wnt signaling appears to depend upon the ability of a particular
Wnt to bind simultaneously to LRP5/6 and a Fzd (He et al., 2004;
MacDonald et al., 2009). The orientation and distance of the
LRP5/6(1-4) region with respect to the membrane cannot be
assessed without knowledge of the intervening LDLR-A repeats,
but the overall conformation seen in the SAXS model of the Fab
complex suggests that repeats 1, 2, and 3 could lie at roughly the
same distance from the membrane (Figure 6D). Thus, a Wnt
bound to either portion of the LRP5/6 ectodomain could access
the Fzd CRD. The overall conformation of the LRP6 ectodomain
also suggests that it may be able to engage two Wnt/Fzd
complexes simultaneously (Bourhis et al., 2010), but further
biophysical and functional studies will be needed to assess
this possibility.evier Inc.
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Protein Constructs, Expression, and Purification
All constructs were cloned into the pACGP67 baculovirus transfer vector (BD
Biosciences). A C-terminal His10 tag was added to the C terminus of each
LRP6 construct, and a C-terminal His6 tag was present on the end of the
Dkk1 constructs. Sf9 cells were infected with LRP6 or Dkk1 viruses and grown
for 72 hr. The cells were pelleted, and the supernatant was adjusted to 1 mM
NiSO4, 5 mM CaCl2, 50 mM Tris (pH 8.0), filtered, loaded onto a Ni
2+-NTA
agarose column (QIAGEN), and eluted with 50 mM Tris (pH 8.0), 300 mM
NaCl, 250 mM imidazole.
The LRP6 constructs were further purified on MonoQ (GE Healthcare) in
50 mM Tris (pH 8.5), 50 mM NaCl and eluted with a linear NaCl gradient.
The eluates were subsequently purified by gel filtration on Superdex 200 (GE
Healthcare) in 50 mM Tris (pH 8.0), 200 mM NaCl. The buffers for LRP6(1-4)
and LRP6(1-2) also included 5% (v/v) glycerol. Dkk1 constructs were purified
by gel filtration in the same buffer (full-length on Superdex 200, Dkk1_N and
Dkk1_C on Superdex 75). After gel filtration, Dkk1_C was further purified on
Hi-Trap HP-SP (GE Healthcare) in 50mM Tris (pH 7.5), 50 mMNaCl and eluted
with a linear NaCl gradient. Dkk1 and LRP6(3-4) point mutants were created by
site-directed mutagenesis (Quikchange; Stratagene) and purified as their wild-
type counterparts.
mAb135 was generated from the hybridoma previously described (Binnerts
et al., 2009), and purified by Protein A affinity chromatography. The Fab frag-
ment was prepared by cleaving mAb135 with immobilized papain (Pierce) and
separated on a Protein A column.
Isothermal Titration Calorimetry
ITC data were measured at 25C in 25 mM Tris (pH 8.0), and 200 mM NaCl,
using a Microcal VP-ITC calorimeter. Full-length Dkk1 or Dkk1_C at 200–
260 mM were injected into a solution of 25–30 mM LRP6(3-4). Dkk1_N at
30 mM was injected into a solution of 2.8 mM LRP6(1-2). Data were analyzed
with the Origin 7 software (Originlab). Measurements of each complex were
performed twice and the average values ± standard deviations are shown in
the figures.
Crystallization, Diffraction Data, and Structure Determination
Small crystals were grown by hanging drop vapor diffusion, using 10 mg/ml
LRP6(3-4)-Dkk1_C complex in 50 mM Tris (pH 8.0) and 200 mM NaCl
and a reservoir solution containing 10%–15% PEG3350, 100 mM Tris
(pH 8.5), and 100 mM LiSO4 and used for repeated rounds of streak seeding
with the same reservoir. Crystals were cryoprotected in a solution of mother
liquor containing 15%–20% glycerol. Diffraction data are summarized in
Table 1.
Initial phases were obtained by molecular replacement with PHASER
(McCoy et al., 2007), using four copies of the LDLR b-propeller/EGF structure
(PDB 1IJQ) (Jeon et al., 2001) as a search model. Density-modified SIRAS
phases calculated from a weak two-site HgCl2 derivative using CNS (Bru¨nger
et al., 1998) at 4 A˚ resolution confirmed the location of the four repeats. Signif-
icantly, the two Hg sites were located next to the single free cysteine residue in
LRP6(3-4), Cys1032, present in each of the two LRP6(3-4) copies. A phase-
combined map using these SIRAS phases with the molecular replacement
phases was examined along with the MR-phased map. The model was built
with Coot (Emsley and Cowtan, 2004) and refined with Phenix (Adams et al.,
2002) and BUSTER (Blanc et al., 2004). After several rounds of refining the
two LRP6(3-4) molecules, interpretable electron density for the single
Dkk1_C became evident. Noncrystallographic symmetry restraints were
imposed in initial rounds of refinement but dropped in the later stages. Buried
surface area calculations were calculated with CNS, and coordinate superpo-
sitions were computed in Coot.
Wnt Signaling Assays
L-cells stably transfected with TOPFLASH and LacZ constructs (LSL cells)
were seeded in 96-well plates in DMEM containing 10% FBS. The cells were
subsequently treated with 103 diluted Wnt-3a conditioned media and the
appropriate Dkk1 and/or LRP6(3-4) construct. Luciferase reporter activity
was measured in a Veritas Luminometer (Turner Biosystems). Assays were
carried out in triplicate, and relative luciferase units were normalized to LacZ.DevelopmeGel Filtration and Native PAGE Binding Assays
Purified proteins or protein complexes were incubated with potential binding
partners for 1 hr at room temperature or overnight at 4C. For analytical
gel filtration, the mixture was applied to a Superdex 200 HR10/30 column
(GE Healthcare) in the buffers noted above, and fractions analyzed by SDS-
PAGE. For native PAGE, samples were mixed with 53 native gel loading buffer
(250mMTris-HCl [pH 6.8], 0.5%w/v bromophenol blue, 50%glycerol), loaded
into a 4%–15% Tris-glycine gel (Bio-Rad) in Tris-glycine running buffer, and
run at 100 V at 4C for 2 hr. Gels were analyzed by Coomassie blue staining,
or by western blotting with anti-His6 HRP conjugated antibodies (QIAGEN)
or anti-Dkk1 polyclonal antibodies (R&D systems).
SAXS Data Acquisition and Analysis
SAXS data were measured on SSRL beamline 4-2 in the range 0.00965 A˚-1%
q% 0.542 A˚-1 (q = 4psin(q)/l) from solutions of LRP6(1-4)-Fab135 and LRP6(1-
4)-Dkk1 complexes at four concentrations between 0.375 and 3 mg/ml, and
0.625 and 5 mg/ml, respectively. Samples were loaded into a 1.5 mm quartz
capillary flow cell maintained at 20C, and 153 1 s exposures were measured
for each concentration. The raw scattering data were normalized to the inci-
dent beam intensity and buffer scattering subtracted. Individual scattering
curves were visually inspected prior to averaging to ensure that radiation
damage was minimal. Scattering curves from different concentrations were
scaled andmerged with PRIMUS (Konarev et al., 2003) to produce a low-noise
curve (Figure 6A).
Ab initio shape determinations were computed with DAMMIF (Franke and
Svergun, 2009) using data in the range 0.012 A˚-1 % q % 0.15 A˚-1. Twelve
independent models for each complex were aligned and averaged using
SUPCOMB and DAMAVER to minimize the normalized spatial discrepancy
(NSD) between runs (Kozin and Svergun, 2001; Volkov and Svergun, 2003).
The mean ± variation NSD values were 0.83 ± 0.057 and 0.75 ± 0.047 for the
Fab135 and Dkk1 complexes, respectively. The averagedmodels were filtered
to remove low occupancy and loosely connected atoms based on the exper-
imentally determined excluded volume of the particle with DAMFILT. PDB
entry 1N8Z was used for the Fab model. Scattering amplitudes were calcu-
lated from the models with CRYSOL (Svergun et al., 1995).
The molecular mass of the LRP6(1-4)-Dkk1 complex was obtained from I(0)
using water as the calibration standard and assuming a protein partial specific
volume of 0.7586 cm3/g (Orthaber et al., 2000) (Figure S6). The calculated
protein mass is 167 kDa (140.2 LRP6(1-4) + 26.5 Dkk1). The precise composi-
tion of N-linked carbohydrates on the LRP6(1-4) and Dkk1 produced in Sf9
cells is unknown, but the major species seen by mass spectrometry of Sf9
expressed LRP6(3-4), which has five N-linked sites, is approximately
6.5 kDa larger than the calculated protein mass (data not shown). Thus,
a reasonable estimate for the total mass of carbohydrate in the complex is
13 kDa (ten sites on LRP6(1-4), one on Dkk1; assuming on average 6.5 sugar
residues per site [Harrison and Jarvis, 2006]). The mass obtained from I(0) is
proportional to (scattering contrast x partial specific volume)-2. The scattering
contrast and partial specific volume of carbohydrates are approximately
1.83 and 0.83 that of proteins, respectively (Durschlag, 1989; Koch et al.,
2003), so the molecular mass contribution from the carbohydrate will be over-
estimated by 6 kDa using protein scattering contrast and partial specific
volume values.
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